Panel: CDMO Consolidation: Strategic Partnerships or Dangerous Dependencies?

Tuesday, October 6, 2026 11:35 AM to 12:20 PM · 45 min. (CET)
Hall 10 - 10K69
Manufacturing 5.0
Manufacturing

Information

Industry executives debate whether the trend toward fewer, deeper CDMO relationships enhances operational excellence or creates unacceptable supply chain vulnerabilities. As pharmaceutical companies simplify their supplier networks, this panel examines the strategic calculus behind consolidation decisions and the hidden risks of dependency on a small number of manufacturing partners.

Key Discussion Points:

- Risk-Benefit Analysis of Consolidation: Evaluating operational efficiency gains against single-point-of-failure vulnerabilities in critical supply chains

- Redundancy Strategies: Practical approaches to maintaining backup capacity without sacrificing the benefits of strategic partnerships

- Relationship Management: How to structure CDMO partnerships that deliver integration benefits while preserving flexibility and negotiating leverage

Join the event!

See all the content and easy-to-use features by logging in or registering!